Clinical trial

Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With…

NCT00194857 · Weill Medical College of Cornell University, Other · Terminated

Key facts

NCT number NCT00194857
Title Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin
Official title A Randomized Clinical Trial Comparing Two Management Strategies for Treatment of Neutropenia and Anemia Associated With Pegylated Interferon Plus Ribavirin Treatment of Compensated Chronic Hepatitis C in Adult Subjects Infected With HIV.
Lead sponsor Weill Medical College of Cornell University, Other
Collaborators Schering-Plough Industry
Status Terminated
Phase Phase 4
Study type Interventional
Conditions Anemia, Neutropenia, Hepatitis C Virus, HIV Infections
Intervention type Drug
Interventions erythropoietin, GCSF
Start date Feb 1, 2002
Primary completion Dec 1, 2005
Completion Dec 1, 2005
First posted Sep 19, 2005
Last update posted Dec 17, 2012
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies